Cited by 118Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

RUNX1/AML1: A Central Player in Hematopoiesis

Okuda, Tsukasa, Nishimura, Motohiro, Nakao, Mitsushige, Fujitaa, Yasuko·2001·International Journal of Hematology

Abstract

It has been well established that a number of transcription factors play critical roles in regulating the fate of hematopoietic stem cell populations. One of them is the leukemia-associated transcription factor acute myeloid leukemia 1 (AML1; also known as runt-related transcription factor 1, or RUNX1). This gene was originally cloned from the breakpoint of the t(8;21) reciprocal chromosome translocation and was later recognized as one of the most frequent targets of leukemia-associated gene aberrations. Gene-targeting experiments revealed that transcriptionally active AML1 is essential for the establishment of definitive hematopoiesis. More specifically, this gene functions in the emergence of the hematopoietic progenitor cells from the hemogenic endothelium by budding in the aorta-gonad-mesonephros region, and its expression points to the sites with strong potential for the emergence of hematopoietic stem cells. This review discusses aspects of the biologic properties of AML1 in early hematopoietic development.

Integrity signals

Registry

Crossref · 10.1007/bf02982057

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RUNX1 is a critical regulator of haematopoiesis that frequently participates in leukaemia-associated gene aberrations, including RUNX1-RUNX1T1 fusion recurrent in myeloid malignancies.

    “RUNX1 is a critical regulator of haematopoiesis that frequently participates in leukaemia-associated gene aberrations, including the RUNX1–RUNX1T1 (AML1–ETO9a) fusion recurrent in myeloid malignancies.44”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Okuda, T., Nishimura, M., Nakao, M., & Fujitaa, Y.
Affiliations
Kyoto Prefectural University of Medicine (JP)
Corresponding author
Okuda, Tsukasa
Venue
International Journal of Hematology
Published
2001-10
Volume
74
Issue
3
Pages
252-257
ISSN
  • 0925-5710 (ISSN-L)
  • 1865-3774
OpenAlex
W1982012088
Cited by
118
References
48
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 4 · 2012: 2
FWCI
1.45
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Hematology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
RUNX1, hematopoiesis, hematopoietic stem cells, hematopoietic progenitor cells, hemogenic endothelium, aorta-gonad-mesonephros, transcription factors, definitive hematopoiesis, gene targeting
MeSH terms
Animals, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Proto-Oncogene Proteins, Transcription Factors, Neovascularization, Physiologic, Core Binding Factor Alpha 2 Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review